Company intelligence / Profile preview

CICC Capital

Beijing, China

Ownership: Private
Development stage: Other

Overview

CICC Capital is the private equity investment arm of China International Capital Corporation that manages RMB and USD funds, including sector-focused funds in areas such as healthcare and biologic medicines, but it is an investment firm and does not itself develop drugs or run clinical trials.[5][2]

Industry: Investors

Partnerships

AstraZeneca-CICC Healthcare Investment Fund (joint healthcare investment fund between AstraZeneca and CICC Capital)[4][10]

Beyond the preview

Go deeper on CICC Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CICC Capital.

Explore the full profile